Literature DB >> 10571629

Paradoxical expression of E-cadherin in prostatic bone metastases.

A A Bryden1, A J Freemont, N W Clarke, N J George.   

Abstract

OBJECTIVE: To determine whether the calcium-dependent cell adhesion molecule E-cadherin is expressed in metastatic deposits of prostate cancer in bone. PATIENTS AND METHODS: Ten bone biopsies containing metastatic deposits of untreated prostatic cancer were obtained and immunohistochemically stained for E-cadherin with the monoclonal antibody HECD-1, using the streptavidin-biotin complex technique. Benign prostatic tissue was used as the control.
RESULTS: Of the 10 specimens, nine showed positive expression of E-cadherin, graded as strong in four. E-cadherin expression was strongest in well-differentiated metastases and decreased with increasing tumour grade. In some specimens there were mixed patterns of expression.
CONCLUSION: E-cadherin is strongly expressed in prostatic bone metastases and the degree of expression appears to reflect local tumour grade. This suggests that loss of E-cadherin expression may not be critically linked to metastatic potential.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10571629     DOI: 10.1046/j.1464-410x.1999.00378.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  13 in total

Review 1.  Molecular mechanisms of metastasis in prostate cancer.

Authors:  Noel W Clarke; Claire A Hart; Mick D Brown
Journal:  Asian J Androl       Date:  2008-12-01       Impact factor: 3.285

2.  miR-301a expression: A prognostic marker for prostate cancer.

Authors:  Chendil Damodaran; Trinath P Das; A M Sashi Papu John; Suman Suman; Venkatesh Kolluru; Targhee J Morris; Erin N Faber; Shesh N Rai; Jamie C Messer; Houda Alatassi; Murali K Ankem
Journal:  Urol Oncol       Date:  2016-04-26       Impact factor: 3.498

Review 3.  TGF-beta and BMP7 interactions in tumour progression and bone metastasis.

Authors:  Jeroen T Buijs; Niek V Henriquez; Petra G M van Overveld; Geertje van der Horst; Peter ten Dijke; Gabri van der Pluijm
Journal:  Clin Exp Metastasis       Date:  2007-11-16       Impact factor: 5.150

4.  BMP7, a putative regulator of epithelial homeostasis in the human prostate, is a potent inhibitor of prostate cancer bone metastasis in vivo.

Authors:  Jeroen T Buijs; Cyrill A Rentsch; Geertje van der Horst; Petra G M van Overveld; Antoinette Wetterwald; Ruth Schwaninger; Niek V Henriquez; Peter Ten Dijke; Fran Borovecki; Regula Markwalder; George N Thalmann; Socrates E Papapoulos; Rob C M Pelger; Slobodan Vukicevic; Marco G Cecchini; Clemens W G M Löwik; Gabri van der Pluijm
Journal:  Am J Pathol       Date:  2007-09       Impact factor: 4.307

5.  Characterization of the Hoechst 33342 side population from normal and malignant human renal epithelial cells.

Authors:  Sanjai K Addla; Mick D Brown; Claire A Hart; Vijay A C Ramani; Noel W Clarke
Journal:  Am J Physiol Renal Physiol       Date:  2008-07-09

Review 6.  [How do metastases of urological tumors develop?].

Authors:  M Rose; R Knüchel
Journal:  Urologe A       Date:  2014-06       Impact factor: 0.639

7.  Loss of function of e-cadherin in embryonic stem cells and the relevance to models of tumorigenesis.

Authors:  Lisa Mohamet; Kate Hawkins; Christopher M Ward
Journal:  J Oncol       Date:  2010-12-09       Impact factor: 4.375

8.  Quantum dots for multiplexed detection and characterisation of prostate cancer cells using a scanning near-field optical microscope.

Authors:  Kelly-Ann D Walker; Claire Morgan; Shareen H Doak; Peter R Dunstan
Journal:  PLoS One       Date:  2012-02-09       Impact factor: 3.240

9.  Development of an orthotopic model of human metastatic prostate cancer in the NOD-SCIDγ mouse (Mus musculus) anterior prostate.

Authors:  Federico F Cifuentes; Rodrigo H Valenzuela; Héctor R Contreras; Enrique A Castellón
Journal:  Oncol Lett       Date:  2015-07-22       Impact factor: 2.967

10.  Gene expression analysis of bone metastasis and circulating tumor cells from metastatic castrate-resistant prostate cancer patients.

Authors:  Won Jin Cho; Daniel S M Oliveira; Abdo J Najy; Leandro E Mainetti; Hussein D Aoun; Michael L Cher; Elisabeth Heath; Hyeong-Reh C Kim; R Daniel Bonfil
Journal:  J Transl Med       Date:  2016-03-15       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.